Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Rossari Biotech's Enterprise Value is ₹32,113 Mil.
Rossari Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2,311 Mil. Therefore, Rossari Biotech's EV-to-EBIT ratio for today is 13.90.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Rossari Biotech's Enterprise Value is ₹32,113 Mil.
Rossari Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹3,102 Mil. Therefore, Rossari Biotech's EV-to-EBITDA ratio for today is 10.35.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Rossari Biotech's Enterprise Value is ₹32,113 Mil.
Rossari Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹23,964 Mil. Therefore, Rossari Biotech's EV-to-Revenue ratio for today is 1.34.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Rossari Biotech (NSE:ROSSARI) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Rossari Biotech's current Enterprise Value is ₹32,113 Mil.
Rossari Biotech's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2,311 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Rossari Biotech's current Enterprise Value is ₹32,113 Mil.
Rossari Biotech's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,102 Mil.
Rossari Biotech's current Enterprise Value is ₹32,113 Mil.
Rossari Biotech's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹23,964 Mil.
Rossari Biotech's current Enterprise Value is ₹32,113 Mil.
Rossari Biotech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
Rossari Biotech's current Enterprise Value is ₹32,113 Mil.
Rossari Biotech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech Enterprise Value Related Terms
Rossari Biotech Enterprise Value Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Enterprise Value Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Enterprise Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Rossari Biotech's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech (NSE:ROSSARI) has a Enterprise Value of ₹32,113 Mil as of Jul. 01, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rossari Biotech and its competitors.
Is Rossari Biotech's Enterprise Value too high?
Rossari Biotech's current Enterprise Value is ₹32,113 Mil. Overall, Rossari Biotech has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Enterprise Value compare to LIN and SHW?
Rossari Biotech's Enterprise Value of ₹32,113 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Chemicals company?
A good Enterprise Value depends on the Chemicals industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current Enterprise Value is ₹32,113 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,002.43, compared to a current price of ₹525.35 — trading 47.6% below its estimated fair value. The current Enterprise Value is ₹32,113 Mil. Rossari Biotech's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Enterprise Value is ₹32,113 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹525.35 is trading 47.6% below its estimated GF Value™ of ₹1,002.43.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Enterprise Value: ₹32,113 Mil
GF Value™: ₹1,002.43 vs. price of ₹525.35 (47.6% below fair value)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
84GF Score
Get the complete analysis for NSE:ROSSARI
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
